Wikisage, the free encyclopedia of the second generation, is digital heritage
Epilepsy: Difference between revisions
Jump to navigation
Jump to search
m (ref) |
m (rfz) |
||
| Line 3: | Line 3: | ||
*symptomatic epilepsy | *symptomatic epilepsy | ||
*provoked epilepsy | *provoked epilepsy | ||
* | *cryptogenic epilepsy | ||
<ref>[http://onlinelibrary.wiley.com/doi/10.1111/j.1528-1167.2011.03041.x/epdf The etiologic classification of epilepsy]</ref> | <ref>[http://onlinelibrary.wiley.com/doi/10.1111/j.1528-1167.2011.03041.x/epdf The etiologic classification of epilepsy]</ref> | ||
It is difficult to distinguish between genetic and cryptogenic. | It is difficult to distinguish between genetic and cryptogenic syndromes. | ||
Morbility data is difficult to interpret when WHO states 50 millions persons affect by '''epilepsy'''<ref>(Chung 2015)</ref> | Morbility data is difficult to interpret when WHO states 50 millions persons affect by '''epilepsy'''<ref>(Chung 2015)</ref> | ||
Revision as of 16:42, 25 July 2015
Classification of ethiology could divided in four categories:
- idiopathic epilepsy
- symptomatic epilepsy
- provoked epilepsy
- cryptogenic epilepsy
[1] It is difficult to distinguish between genetic and cryptogenic syndromes.
Morbility data is difficult to interpret when WHO states 50 millions persons affect by epilepsy[2]
nonadherence appears to be associated with increased health care costs,nevertheless XR-medicine appears as strategy to overcome compliance AED [3]
ILAE Classification
[4] [5] A new perspective forEpileptic Disorders
Links
Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population Dravet's syndrome
| References: |
|